HAPILA GmbH was founded in 2007 as an independent enterprise by scientists and technicians with long-standing experience in the pharmaceutical industry. Since then we have experienced continuous growth and establishment of a successful business organization, international client base and regulatory compliance structure for cGMP-API manufacturing, European certification and grant of European and US patents on our proprietary HAPIpur® technology. As a contract developer and manufacturer (CDMO), HAPILA provides high-value production of active pharmaceutical ingredients (APIs) for pharma, biotech and fine chemicals clients. Our mission is to be highly efficient bridge-builders between API production and pharmaceutical end-use, supplying highest quality, potency and safety products in compliance with Good Manuafacturing Practice (GMP) and environmental guidelines. All HAPILA APIs are manufactured in-house at our GMP certified facility at Gera, Thuringia, in east-central Germany, where our highly qualified team is focused on product quality and customer satisfaction.